Brandon Capital

Melbourne, Australia · DeepTech Native
Out of Scope

Bio

Brandon Capital Brandon Capital was founded in 2007 and has grown into Australia's largest life sciences venture capital firm, surpassing $1B in total AUM. Fund VI closed at AU$439M (US$288M) in 2024, the largest to date. The firm is the licensed manager for the Australian Government's $500M Biomedical Translation Fund, which provides dollar- for-dollar matching, and the National Reconstruction Fund committed an additional $150M for next-generation Australian medical breakthroughs. The investmen

Industries

BiotechMedTech

Stages

SeedSeries A

Geography

Rest of WorldEuropeUS

Notable investments

  • Vaxxas
  • AdvanCell
  • Myricx Bio
  • OncoRes Medical
  • PolyActiva